SCHEMBL29314660

SCHEMBL29314660

C[C@@H]1CCCCC12COC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2786155 1.00 — —
SCHEMBL16659516 0.85 — —
SCHEMBL7529686 0.79 — —
SCHEMBL23505340 0.79 MAPT (0.32) —
SCHEMBL15927296 0.79 — —
SCHEMBL16659517 0.77 — —
SCHEMBL15546449 0.76 — —
SCHEMBL17348570 0.74 — —
SCHEMBL1218895 0.74 — —
SCHEMBL16666909 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400502-A2 TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Shionogi & Co., Ltd (JP) 2024-07-17 — — EP disclosed
Send feedback